145 related articles for article (PubMed ID: 27577083)
21. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
22. Subtype-specific alterations of the Wnt signaling pathway in breast cancer: clinical and prognostic significance.
Mukherjee N; Bhattacharya N; Alam N; Roy A; Roychoudhury S; Panda CK
Cancer Sci; 2012 Feb; 103(2):210-20. PubMed ID: 22026417
[TBL] [Abstract][Full Text] [Related]
23. Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma.
Cho O; Chun M; Oh YT; Noh OK; Chang SJ; Ryu HS; Lee EJ
Tumour Biol; 2017 Oct; 39(10):1010428317733144. PubMed ID: 29022484
[TBL] [Abstract][Full Text] [Related]
24. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
[TBL] [Abstract][Full Text] [Related]
25. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
[TBL] [Abstract][Full Text] [Related]
27. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness.
Tsujikawa H; Masugi Y; Yamazaki K; Itano O; Kitagawa Y; Sakamoto M
Hum Pathol; 2016 Apr; 50():24-33. PubMed ID: 26997435
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
[TBL] [Abstract][Full Text] [Related]
30. Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.
Ho CK; Kornaga EN; Klimowicz AC; Enwere EK; Dean M; Bebb GD; Phan T; Ghatage P; Magliocco AM; Lees-Miller SP; Doll CM
Gynecol Oncol; 2017 Apr; 145(1):176-184. PubMed ID: 28131528
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
Lim A; Sia S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
[TBL] [Abstract][Full Text] [Related]
32.
Liang J; Zhou H; Peng Y; Xie X; Li R; Liu Y; Xie Q; Lin Z
Biomed Res Int; 2016; 2016():4923903. PubMed ID: 27843945
[TBL] [Abstract][Full Text] [Related]
33. Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.
Nout RA; Bosse T; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; van Eijk R; Ter Haar NT; Smit VT
Gynecol Oncol; 2012 Sep; 126(3):466-73. PubMed ID: 22609107
[TBL] [Abstract][Full Text] [Related]
34. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
[TBL] [Abstract][Full Text] [Related]
36. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
[TBL] [Abstract][Full Text] [Related]
37. Aberrant beta-catenin and LEF1 expression may predict the clinical outcome for patients with oropharyngeal cancer.
Papagerakis P; Pannone G; Shabana AH; Depondt J; Santoro A; Ghirtis K; Berdal A; Papagerakis S
Int J Immunopathol Pharmacol; 2012; 25(1):135-46. PubMed ID: 22507326
[TBL] [Abstract][Full Text] [Related]
38. Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer.
Hua F; Liu S; Zhu L; Ma N; Jiang S; Yang J
Biomed Pharmacother; 2017 Aug; 92():1128-1134. PubMed ID: 28628975
[TBL] [Abstract][Full Text] [Related]
39. Expression of ERCC1 and TUBB3 in locally advanced cervical squamous cell cancer and its correlation with different therapeutic regimens.
Zwenger AO; Grosman G; Iturbe J; Leone J; Vallejo CT; Leone JP; Verdera PP; Pérez JE; Leone BA
Int J Biol Markers; 2015 Jul; 30(3):e301-14. PubMed ID: 26165688
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.
Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
Histopathology; 2007 Mar; 50(4):453-64. PubMed ID: 17448021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
